<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: GEN News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=gen</link><description>Latest Financial News for Genmab</description><language>en-us</language><lastBuildDate>Fri, 3 Apr 2009 10:26:54 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Arzerra(tm) (ofatumumab) Granted Priority Review by FDA (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090403/162478.html</link><description>COPENHAGEN, Denmark, April 3, 2009 -- Genmab today announced that the US Food and Drug Administration has accepted the Biologics License Application for Arzerra to treat patients whose chronic lymphocytic leukemia is resistant to previous therapies and has granted ofatumumab priority review status.</description><guid isPermaLink="false">yahoo_finance/282324635</guid><pubDate>Fri, 3 Apr 2009 10:26:54 Etc/GMT</pubDate></item><item><title>Genmab A/S Summons Annual General Meeting (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090325/161907.html</link><description></description><guid isPermaLink="false">yahoo_finance/128689914</guid><pubDate>Wed, 25 Mar 2009 08:34:26 Etc/GMT</pubDate></item><item><title>Arzerra(TM) (ofatumumab) MAA Accepted by EMEA (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090226/160465.html</link><description></description><guid isPermaLink="false">yahoo_finance/1846435914</guid><pubDate>Thu, 26 Feb 2009 21:57:35 Etc/GMT</pubDate></item><item><title>Genmab Announces Year End 2008 Financial Results (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090224/160238.html</link><description></description><guid isPermaLink="false">yahoo_finance/2478162048</guid><pubDate>Tue, 24 Feb 2009 18:30:40 Etc/GMT</pubDate></item><item><title>GlaxoSmithKline and Genmab Seek European Marketing Authorisation of Arzerra (Ofatumumab) in Advanced Stage Blood Cancer (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090205/159093.html</link><description></description><guid isPermaLink="false">yahoo_finance/3258245790</guid><pubDate>Thu, 5 Feb 2009 19:47:39 Etc/GMT</pubDate></item><item><title>Genmab Announces Interim Results in Pivotal Study of Zalutumumab in Head and Neck Cancer (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090105/157067.html</link><description></description><guid isPermaLink="false">yahoo_finance/2149693028</guid><pubDate>Mon, 5 Jan 2009 16:25:21 Etc/GMT</pubDate></item></channel></rss><!-- c9.finance.sp2.yahoo.com compressed/chunked Tue Dec 22 07:07:01 PST 2009 -->
